Weaponizing the Microbiome Against Alzheimer’s Disease

Time: 8:00 am


  • Investigating Alzheimer’s disease in the context of the microbiome: what do biopharma need to know?
  • Analyzing how microbial DNAs involvement in Alzheimer’s disease can be exploited as a treatment strategy against it
  • Revealing how DNA of some species triggers protein misfolding and learning how this influences Alzheimer’s development and progression